Cartesian Therapeutics
RNAC
#6848
Rank
S$0.59 B
Marketcap
$23.27
Share price
1.82%
Change (1 day)
-45.29%
Change (1 year)

Cartesian Therapeutics (RNAC) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : S$0.60 Billion

According to Cartesian Therapeutics's latest financial reports the company's total liabilities are S$0.60 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cartesian Therapeutics - Total liabilities on balance sheet (from 2015 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31S$0.98 B918.86%
2022-12-31S$96.6 M-47.98%
2021-12-31S$0.18 B-23.48%
2020-12-31S$0.24 B97.44%
2019-12-31S$0.12 B80.31%
2018-12-31S$68.17 M3.41%
2017-12-31S$65.92 M32.62%
2016-12-31S$49.7 M-77.94%
2015-12-31S$0.22 B55.07%
2014-12-31S$0.14 B